Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Pacira BioSciences Affirms FY2025 Sales Guidance of $725.00M-$765.00M vs $752.21M Est

Author: Benzinga Newsdesk | May 08, 2025 03:01pm
Pacira BioSciences (NASDAQ:PCRX) affirms FY2025 sales outlook from $725.00 million-$765.00 million to $725.00 million-$765.00 million vs $752.21 million estimate.

Posted In: PCRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist